- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Panacea Innovation Ltd
- Signature - Title
- /s/ James Huang - James Huang, Founding Managing Partner
- Location
- Grand Cayman, Cayman Islands
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Panacea Innovation Ltd.
Notify me when Panacea Innovation Ltd files a new Schedule 13D/G report.
⭐ Subscribe ⭐Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Panacea Innovation Ltd
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CNTB | Connect Biopharma Holdings Limited | Ordinary Shares | 25% | $13,950,000 | 13,950,000 | Panacea Innovation Limited | 21 Jul 2025 | ||
| CASI | CASI Pharmaceuticals, Inc. | Ordinary Shares | 22% | $4,698,042 | +$999,856 | 4,651,527 | +27% | James Huang | 16 Dec 2025 |
| CNTB | Connect Biopharma Holdings Limited | Ordinary Shares | 21% | $36,848,000 | +$3,248,000 | 13,160,000 | +9.7% | Panacea Innovation Limited | 31 Mar 2026 |
| ATRA | Atara Biotherapeutics, Inc. | Common Stock | 20% | -$1,154,619 | 1,632,345 | -4.7% | Panacea Innovation Limited | 12 Jan 2026 | |
| ATRA | Atara Biotherapeutics, Inc. | Common Stock, par value $0.0001 per share | 9.5% | $4,180,000 | 550,000 | Panacea Venture Healthcare Fund II, L.P. | 30 Jan 2025 | ||
| ADAG | Adagene Inc. | Ordinary Shares | 3.8% | $4,469,175 | -$1,564,211 | 2,250,000 | -26% | Panacea Venture Healthcare Fund II, L.P. | 30 Sep 2025 |
| AMLX | Amylyx Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 2.6% | $11,792,000 | 2,200,000 | Panacea Venture Healthcare Fund II, L.P. | 31 Dec 2024 | ||
| MRNS | Marinus Pharmaceuticals, Inc. | Common Stock | 0% | $0 | 0 | Panacea Venture Healthcare Fund II, L.P. | 31 Dec 2024 |
Schedules 13D/G Reported by Panacea Innovation Ltd:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.